Laval University to hold world’s first Zika vaccine test on humans

The Infectious Disease Research Centre at Laval University (CRI) and the Research Centre of Quebec-Laval University Hospital (CHU) have announced the completion of a first in Canada study clinic on a vaccine against Zika. “We are the first team in the world to have passed all stages of regulatory efficiency and safety and to obtain permission from the Food and Drug Administration (FDA: US Agency for Food and Drug Administration) and Health Canada development of the vaccine and we are very proud, “said Gary Kobinger, PhD in microbiology professor at the Faculty of medicine at Laval University, researcher at the University Hospital research Center, Director of CRI and world authority vaccine research. Zika virus is transmitted mainly by mosquitoes. Although most infections are mild, it can still cause miscarriages or birth of babies with an abnormally small head (microcephaly), if the mother is infected during pregnancy. “There is currently no treatment or vaccine...